疫神 Frontiers | CXCL17 Is a Specific Diagnostic Biomarker for Severeの詳細情報
Frontiers | CXCL17 Is a Specific Diagnostic Biomarker for Severe。An engineered IL-21 variant is a potent antitumor candidate for。Cytokeratin 19 antibody (10712-1-AP) | Proteintech。Frontiers | Sudocetaxel Zendusortide (TH1902) triggers the cGAS。商品の説明はありません